SAINT PETERSBURG, FL -- (Marketwire) -- 08/14/08 -- Isys Medical, Inc. (PINKSHEETS: IMDN stock),
a next generation medical device company that seeks to make a difference in
the Telemedicine and medical device industry, by offering solutions that
can change or alter the way major health problems are addressed through
innovative, often disruptive technologies, announces shareholder updates on
the following events:
-- For providing transparency to our investors, the Company will file Form 211 with Finra to start the process of becoming fully reporting Pink. The process should begin in the next two weeks or so. If and when Finra approves our application, Isys will attain further visibility and market attention to our business, our products and our future among the early leaders in Telemedicine. Currently the trading will be limited until our application becomes effective by Finra.
-- The Company has been successful in completing the acquisition of the remaining percentage ownership of DDI. Since the initial acquisition of DDI by the Company two years ago, DDI has been able to attract investments and also world renowned diabetes medical Doctors and researchers as board advisors. DDI has also been successful in completing its fourth generation prototype device, beginning to establish relationships with major manufacturers, carriers and channel distributors globally. The Company is currently working on a final prototype which is slated for market in the second or third quarter of 2009, subject to FDA clearance. This will allow Isys Medical to produce devices that will combat the terrible effects of Diabetes, currently growing in epidemic rates.
-- To create transparency for our investors, the Company has made available our recent annual report for year ending March 2008, according to GAAP. All our future financials will be available on our website, on Pinksheets.com (if available) or Edgar (if possible). You can download the full annual report by visiting; http://www.isysmedical.com/financials/3.31.08.pdf.
The Company appreciates the understanding demonstrated by investors during
this important and exciting transition. We invite you to visit our website
for more information: http://www.isysmedical.com
Forward-Looking Statements
This press release may contain forward-looking statements covered within
the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements relate to, among other things, plans and timing
for the introduction or enhancement of our services and products,
statements about future market conditions, supply and demand conditions,
and other expectations, intentions and plans contained in this press
release that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability to
develop and supply products and services that we may not produce today and
that meet defined specifications. When used in this press release, the
words "plan," "expect," "believe," and similar expressions generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties,
including, but not limited to, changes in technology and changes in
pervasive markets.
